Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

SPIRE 1 & 2: A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability of PF-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events. Atherosclerotic Cardiovascular Disease (CVD)

Project: Types of projectsProject

View graph of relations
Period01/07/2015 → …

ID: 45616202